Single-Site Investigator-Initiated Clinical Trials (R61/R33)
Main page content
Purpose: This Funding Opportunity Announcement (FOA) supports applications to develop and implement phase II and beyond investigator-initiated single-site clinical trials. Applications submitted to this FOA must be relevant to the research mission of the NHLBI and meet the NIH definition of a clinical trial (see NOT-OD-15-015)...
Deadline: February 14, 2017; June 14, 2017; October 11, 2017; February 13, 2018; June 14, 2018; October 11, 2018; February 13, 2019; June 14, 2019, by 5:00 PM local time of applicant organization